T1	Participants 52 108	children and adolescents with autism spectrum disorders.
T2	Participants 923 1165	months, 58 of 210 families with children with autism spectrum disorders participating in a larger study of phenotypic and genotypic factors reported significant concerns about blood draws and elected to use the Blood Draw Intervention Program
